BioLife Solutions, Inc. Income (Loss) from Continuing Operations, Per Basic Share
BioLife Solutions, Inc. (BLFS) reported Income (Loss) from Continuing Operations, Per Basic Share of $0.92 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2026-08-06
- BioLife Solutions, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2026-06-30 was $0.92.
- BioLife Solutions, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2026-03-31 was $0.02, a 100.00% increase year-over-year.
- BioLife Solutions, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2025-09-30 was $0.01.
- BioLife Solutions, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2025-06-30 was -$0.32.
- BioLife Solutions, Inc. income (loss) from continuing operations, per basic share for fiscal 2025 was -$0.25.
- BioLife Solutions, Inc. income (loss) from continuing operations, per basic share for fiscal 2024 was -$0.19.
- BioLife Solutions, Inc. income (loss) from continuing operations, per basic share for fiscal 2023 was -$0.28, a 2900.00% decline from fiscal 2022.
- BioLife Solutions, Inc. income (loss) from continuing operations, per basic share for fiscal 2022 was $0.01.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 12 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.92 10-Q · filed 2026-08-06 | $0.95 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | $0.02 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | -$0.25 10-K · filed 2026-02-26 | |||||||
| 2025-09-30 | $0.01 10-Q · filed 2025-11-06 | -$0.33 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | -$0.32 10-Q · filed 2026-08-06 | -$0.33 10-Q · filed 2025-08-07 | -$0.31 10-Q · filed 2026-08-06 | -$0.34 10-Q · filed 2025-08-07 | ||||
| 2025-03-31 | $0.01 10-Q · filed 2026-05-07 | -$0.01 10-Q · filed 2025-05-08 | ||||||
| 2024-12-31 | -$0.19 10-K · filed 2026-02-26 | -$0.25 10-K · filed 2025-03-03 | ||||||
| 2024-09-30 | -$0.01 10-Q · filed 2025-11-06 | -$0.04 10-Q · filed 2024-11-12 | -$0.20 10-Q · filed 2025-11-06 | -$0.28 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | -$0.12 10-Q · filed 2025-08-07 | -$0.16 10-Q · filed 2024-08-09 | -$0.19 10-Q · filed 2025-08-07 | -$0.25 10-Q · filed 2024-08-09 | ||||
| 2024-03-31 | -$0.07 10-Q · filed 2025-05-08 | |||||||
| 2023-12-31 | -$0.28 10-K · filed 2026-02-26 | -$0.42 10-K · filed 2025-03-03 | ||||||
| 2023-09-30 | -$0.36 10-Q · filed 2024-11-12 | -$0.69 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | -$0.12 10-Q · filed 2024-08-09 | -$0.33 10-Q · filed 2024-08-09 | ||||||
| 2022-12-31 | $0.01 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |